Waters 186004713 Oasis Peptide Method Development 96-well µE
货号 |
描述 |
价格 |
| 186004713 | Oasis Peptide Method Development 96-well µElution Plate, 2 mg Sorbent per Well, 30 µm, 1/pk | 3870.25 |
Oasis Peptide Method Development µElution Plate is designed to simplify the process of sample preparation for the analysis of therapeutic peptides in plasma. The 96-well plate format contains six rows each of two Oasis mixed-mode, ion-exchange chemistries: a strong exchanger (MAX) and a weak cation exchanger (WCX). Sample preparation method development can be quickly and easily achieved with the use of a single SPE protocol. The Oasis Peptide µElution Method Development Plate is sold separately or as a component of the UPLC Therapeutic Peptide Method Development Kit (176001835) and the HPLC Therapeutic Peptide Method Development Kit (176001836).
|
Brand |
Oasis |
|
Product Type |
Solid Phase Extraction |
|
Units per Package |
1 pk |
|
Chemistry |
Method Development |
|
Endcapped |
No |
|
Format |
96-well µElution Plate |
|
Mass Spec Compatibility |
Yes |
|
Mode |
Mixed mode |
|
Particle Size |
30 µm |
|
Pore Size |
80 Å |
|
Sorbent Substrate |
Copolymer |
|
Sorbent Weight |
2 mg |
|
Water Wettable |
Yes |
|
pH Range Min |
0 pH |
|
pH Range Max |
14 pH |
|
Material |
Polypropylene |
|
Number of Wells |
96 |
上一篇：Waters 186004832 DisQuE 150 mg MgSO4, 25 mg PSA & 25 mg C18,
下一篇：Waters 186004834 DisQuE 900 mg MgSO4 & 150 mg PSA, C18, 15 m
